Table 2.
Results – base case analysis and scenario analysis
| PROBABILISTIC RESULTS (discounted) | ||||||||
|---|---|---|---|---|---|---|---|---|
|
Diagnostic test |
Treatment |
Costs |
LYs |
QALYs |
iCosts |
iLY |
iQALYs |
iCERs |
|
Base case |
|
|
|
|
|
|
|
|
| No screen |
Low dose aspirin |
28052 |
20.69 |
15.58 |
|
|
|
|
| ABI screening |
Low dose aspirin |
26548 |
21.79 |
15.66 |
-1503 |
1.10 |
0.007 |
Dominant |
|
Scenario analysis with Clopidogrel | ||||||||
| No screen |
Clopidogrel |
29464 |
22.33 |
15.95 |
|
|
|
|
| ABI |
Clopidogrel |
27681 |
22.57 |
16.17 |
-1783 |
0.24 |
0.22 |
Dominant |
|
PROBABILISTIC RESULTS (undiscounted) | ||||||||
|
Diagnostic test |
Treatment |
Costs |
LYs |
QALYs |
iCosts |
iLY |
iQALYs |
|
|
Base case | ||||||||
| No screen |
Low dose aspirin |
63155 |
26.32 |
19.40 |
|
|
|
|
| ABI screening |
Low dose aspirin |
59544 |
27.47 |
19.50 |
-3611 |
1.15 |
0.11 |
|
|
Scenario analysis with Clopidogrel | ||||||||
| No screen |
Clopidogrel |
67799 |
28.30 |
19.96 |
|
|
|
|
| ABI | Clopidogrel | 63759 | 28.66 | 20.27 | -4039 | 0.36 | 0.31 | |